Huijuan Li

Huijuan Li is currently the Vice President and Global Head of Analytical R&D at GSK, a position held since May 2025. Prior to this role, Huijuan Li served as Vice President of Technology Development at Moderna from September 2016 to April 2025, focusing on CMC strategy and early development portfolio. Huijuan Li's extensive experience at Merck included several leadership roles such as Vice President of AS&T and Director of Analytical Development, where oversight of analytical methods and CMC teams for biologics development was emphasized. Previous roles at Bristol Myers Squibb and GlycoFi, along with academic training as a Post Doc at McGill University and a PhD in Protein Chemistry from the University of Melbourne, further contribute to Huijuan Li's expertise in the field.